Results 151 to 159 of about 278 (159)

ТеÑÑÑÐ²Ð°Ð½Ð½Ñ Ñ ÑиÑÑÐµÐ¼Ð°Ñ Ñа меÑодологÑÑÑ ÑозÑобкипÑогÑамного забезпеÑеннÑ

open access: green, 2010
В. М.; Національний авіаційний університет Боровик   +2 more
openalex   +1 more source

Fast‐Charging of Solid‐State Batteries Enabled by Functional Additives Infused into High‐Mass‐Loading Nickel Manganese Cobalt Cathodes

open access: yesBatteries &Supercaps, EarlyView.
Bottlebrush polymer additives offer a versatile and robust solution to the fundamental transport and contact challenges in all‐solid‐state lithium metal batteries. In this work, high mass loading nickel manganese cobalt cathodes with various polymer additives are prepared, and the electrochemical properties are investigated.
Pascal J. Glomb   +5 more
wiley   +1 more source

A systematic scoping review of metrics utilized to measure antibiotic consumption in hospital settings

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki   +3 more
wiley   +1 more source

Metabolic fate of drugs of abuse and new psychoactive substances: A pilot study on a novel workflow using a zebrafish embryo model combined with human microdosing

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim The aim of this study was to develop a novel workflow to identify human urine biomarkers for drugs of abuse and new psychoactive substances. Metabolites of amphetamine, cocaine, LSD, MDMA, methamphetamine, THC, MDMB‐CHMICA, and MDPPP were first identified in a zebrafish embryo (ZE) metabolism study followed by comparison to most abundant human ...
Simon K. Wellenberg   +7 more
wiley   +1 more source

Safety, tolerability and pharmacokinetics of DNDI‐6148, a novel agent for leishmaniasis: A randomized, controlled, single ascending dose study in healthy participants

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim The benzoxaborole derivative DNDI‐6148 is an antiparasitic agent with activity against multiple Leishmania protozoan species, including L. infantum and L. donovani, which cause visceral leishmaniasis. We investigated the safety, tolerability and pharmacokinetics of single oral doses of DNDI‐6148 in a randomized, parallel‐group, placebo‐controlled ...
Jean‐Yves Gillon   +12 more
wiley   +1 more source

ÐабезпеÑÐµÐ½Ð½Ñ ÑÑлÑÑноÑÑÑ Ð·Ð¾Ð²Ð½ÑÑнÑÑ ÐºÐ»ÑÑÑв маÑÐºÐ¾Ð²Ð°Ð½Ð¾Ñ Ð±Ð°Ð·Ð¸ даниÑ

open access: green, 2015
Светлана Александровна; НТУУ «КПІ» Носок   +1 more
openalex   +1 more source

ÐокалÑзаÑÑÑ ÐºÐ¾Ð½ÑÑолÑÐ½Ð¸Ñ ÑоÑок на ÑаÑакÑеÑÐ½Ð¸Ñ ÑÑагменÑÐ°Ñ Ð·Ð¾Ð±ÑÐ°Ð¶ÐµÐ½Ð½Ñ Ð¾Ð±Ð»Ð¸ÑÑÑ Ð»Ñдини

open access: green, 2015
Валериян Анатольевич; Национальный авиационный университет Швец   +1 more
openalex   +1 more source

Home - About - Disclaimer - Privacy